Company intelligence / Profile preview

EcoR1 Panacea Holdings

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Panacea Acquisition Corp was a publicly traded special purpose acquisition company (SPAC) sponsored by EcoR1 Capital, created to acquire a private biotech company and take it public. In 2021, it completed its business combination with Nuvation Bio, which currently operates as the successor public company.[1][2][3]

Industry: Investors

Beyond the preview

Go deeper on EcoR1 Panacea Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EcoR1 Panacea Holdings.

Explore the full profile